This activity will provide learners with the latest developments in translational medicine for leukemia, lymphoma, and myeloma and how these developments can be incorporated into regimens to improve the outcome of patients with these diseases.
Upon completion of this activity, participants should be better able to:
The Maurice & Marguerite Liberman Distinguished Endowed Chair, Cancer Research
UNM Distinguished Professor, Pathology
UNM School of Medicine
Director & CEO
University of New Mexico Comprehensive Cancer Center
Albuquerque, NM
Harold and Virginia Lash/David Lash Chair, Lymphoma Research
Chief, Lymphoma Division
Dana-Farber Cancer Institute
Boston, MA
Bosworth Chair, Cancer Biology
Professor of Pediatrics and Microbiology, Immunology and Tropical Medicine
Director, Center for Cancer and Immunology Research
Director, Program for Cell Enhancement and Technologies for Immunotherapy
Children’s National Health System
The George Washington University School of Medicine and Health Sciences
Washington, DC
George P. Canellos, MD and Jean S. Canellos Professor, Medicine
Harvard Medical School
Chair, Department of Medical Oncology
Dana-Farber Cancer Institute,
Boston, MA
Investigator, Howard Hughes Medical Institute
Chief, Division of Oncology
Director, Center for Childhood Cancer Research
Jeffrey E. Perelman Distinguished Chair, Department of Pediatrics
Children’s Hospital of Philadelphia
Professor, Department of Pediatrics
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, PA
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources